Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$19.4 - $27.42 $449,109 - $634,773
-23,150 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$25.02 - $54.99 $579,213 - $1.27 Million
23,150 New
23,150 $597,000
Q3 2020

Nov 16, 2020

SELL
$36.42 - $57.0 $496,222 - $776,625
-13,625 Closed
0 $0
Q4 2019

Jan 14, 2020

SELL
$36.21 - $51.4 $720,579 - $1.02 Million
-19,900 Reduced 59.36%
13,625 $583,000
Q3 2019

Oct 31, 2019

SELL
$22.22 - $44.01 $789,765 - $1.56 Million
-35,543 Reduced 51.46%
33,525 $1.21 Million
Q2 2019

Jul 31, 2019

SELL
$23.32 - $28.12 $555,016 - $669,256
-23,800 Reduced 25.63%
69,068 $1.85 Million
Q1 2019

Apr 30, 2019

BUY
$16.17 - $27.38 $662,970 - $1.12 Million
41,000 Added 79.05%
92,868 $2.49 Million
Q3 2018

Nov 13, 2018

BUY
$13.03 - $21.81 $432,179 - $723,394
33,168 Added 177.37%
51,868 $1.08 Million
Q2 2018

Aug 13, 2018

SELL
$15.07 - $22.34 $218,213 - $323,483
-14,480 Reduced 43.64%
18,700 $286,000
Q1 2018

May 14, 2018

BUY
$22.47 - $32.33 $45,389 - $65,306
2,020 Added 6.48%
33,180 $746,000
Q4 2017

Feb 13, 2018

SELL
$26.84 - $39.14 $378,444 - $551,874
-14,100 Reduced 31.15%
31,160 $938,000
Q3 2017

Oct 30, 2017

BUY
$29.49 - $38.37 $1.33 Million - $1.74 Million
45,260
45,260 $1.71 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.54B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.